Literature DB >> 8530042

A locus for cerebral cavernous malformations maps to chromosome 7q in two families.

D A Marchuk1, C J Gallione, L A Morrison, C L Clericuzio, B L Hart, B E Kosofsky, D N Louis, J F Gusella, L E Davis, V L Prenger.   

Abstract

Cavernous malformations (angiomas) affecting the central nervous system and retina can be inherited in autosomal dominant pattern (OMIM 116860). These vascular lesions may remain clinically silent or lead to a number of neurological symptoms including seizure, intracranial hemorrhage, focal neurological deficit, and migraine. We have mapped a gene for this disorder in two families, one of Italian-American origin and one of Mexican-American origin, to markers on proximal 7q, with a combined maximum lod score of 3.92 (theta of zero) with marker D7S479. Haplotype analysis of these families places the locus between markers D7S502 proximally and D7S515 distally, an interval of approximately 41 cM. The location distinguishes this disorder from an autosomal dominant vascular malformation syndrome where lesions are primarily cutaneous and that maps to 9p21.

Entities:  

Mesh:

Year:  1995        PMID: 8530042     DOI: 10.1006/geno.1995.1147

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation.

Authors:  Dominique J Verlaan; Adrian M Siegel; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2002-04-08       Impact factor: 11.025

2.  Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q.

Authors:  L Notelet; F Chapon; S Khoury; K Vahedi; J P Chodkiewicz; P Courtheoux; M T Iba-Zizen; E A Cabanis; B Lechevalier; E Tournier-Lasserve; J P Houtteville
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

3.  Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.

Authors:  Christina L Liquori; Silvana Penco; Judith Gault; Tracey P Leedom; Laura Tassi; Teresa Esposito; Issam A Awad; Luigi Frati; Eric W Johnson; Ferdinando Squitieri; Douglas A Marchuk; Fernando Gianfrancesco
Journal:  Neurogenetics       Date:  2007-12-01       Impact factor: 2.660

Review 4.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

5.  Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation.

Authors:  Valerie L Su; Bertrand Simon; Kyle M Draheim; David A Calderwood
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

Review 6.  Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series.

Authors:  N F Moran; D R Fish; N Kitchen; S Shorvon; B E Kendall; J M Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

Review 7.  Genetics of cerebral cavernous malformations.

Authors:  Nicholas W Plummer; Jon S Zawistowski; Douglas A Marchuk
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

8.  Familial cerebral cavernous malformation: report of a further Italian family.

Authors:  Serena Nannucci; Francesca Pescini; Anna Poggesi; Laura Ciolli; Maria Cristina Patrosso; Alessandro Marocchi; Domenico Inzitari; Silvana Penco; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2009-01-30       Impact factor: 3.307

9.  KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein.

Authors:  Murat Gunel; Maxwell S H Laurans; Dana Shin; Michael L DiLuna; Jennifer Voorhees; Keith Choate; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-24       Impact factor: 11.205

10.  Inherited cavernous malformations of the central nervous system: clinical and genetic features in 19 Swiss families.

Authors:  C Graeni; F Stepper; M Sturzenegger; A Merlo; D J Verlaan; F Andermann; C R Baumann; F Bonassin; D Georgiadis; R W Baumgartner; G A Rouleau; A M Siegel
Journal:  Neurosurg Rev       Date:  2009-09-17       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.